This multi-center, cluster randomized study aimed at improving implementation of vancomycin reducing practices (VRP) in neonatal intensive care units (NICUs). Sites will be recruited and randomized to receive either external facilitation or no external facilitation to assess the effect on center-level fidelity to the core components of VRP implementation. Interventions available to both study arms are directed at hospital staff and includes identification of local champions, educational outreach, unit-level audit \& feedback, and use of a clinical decision support tool.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Enrollment
13
Designated external facilitators will conduct monthly meetings with local champions at each site. Designated facilitators will follow the developed facilitation guide, that includes content area to cover in each meeting, case scenarios as examples, and tips on how to communicate and support the internal facilitators. The goal is to enable problem-solving and support the local champion in implementing VRP with fidelity
Kaiser Permanente Modesto Medical Center
Modesto, California, United States
RECRUITINGKaiser Permanente East Bay - Oakland Medical Center
Oakland, California, United States
RECRUITINGKaiser Permanente Roseville Medical Center
Roseville, California, United States
RECRUITINGKaiser Permanente San Francisco Medical Center
San Francisco, California, United States
RECRUITINGKaiser Permanente San Leandro Medical Center
San Leandro, California, United States
RECRUITINGKaiser Permanente Santa Clara Medical Center
Santa Clara, California, United States
RECRUITINGKaiser Permanente Walnut Creek Medical Center
Walnut Creek, California, United States
RECRUITINGMedical Center of Princeton
Plainsboro, New Jersey, United States
RECRUITINGVirtua Voorhees
Voorhees Township, New Jersey, United States
RECRUITINGLancaster General Hospital
Lancaster, Pennsylvania, United States
RECRUITING...and 3 more locations
Fidelity of VRP use
Proportion of late onset sepsis (LOS) evaluations performed with high fidelity. High fidelity is defined when the evaluation follows all three core components of VRP use.
Time frame: 2.5 years - From beginning of implementation phase to the end of the sustainment phase
Appropriateness/acceptability
Response to questions about whether vancomycin reducing practices (VRP) was agreeable and/or a good fit for the unit measured using validated instruments comprising of 5-point Likert scales (Weiner et al). Participants are offered options ranging from completely disagree (1) to completely agree (5), with higher scores indicating a higher degree of acceptability or feasibility.
Time frame: 2.5 years - From beginning of implementation phase to the end of the sustainment phase
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.